ROYAL BANK OF CANADA - ATYR PHARMA INC ownership

ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 41 filers reported holding ATYR PHARMA INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ATYR PHARMA INC
ValueSharesWeighting
Q2 2019$017
-67.3%
0.00%
Q1 2019$0520.0%0.00%
Q4 2018$0520.0%0.00%
Q3 2018$052
+477.8%
0.00%
Q3 2017$09
+28.6%
0.00%
Q1 2017$0
-100.0%
7
-97.9%
0.00%
Q3 2015$3,000
-62.5%
331
-19.5%
0.00%
Q2 2015$8,0004110.00%
Other shareholders
ATYR PHARMA INC shareholders Q4 2017
NameSharesValueWeighting ↓
Polaris Venture Management Co. V, L.L.C. 1,827,992$33,854,00015.10%
EcoR1 Capital, LLC 836,860$15,499,0005.17%
Rock Springs Capital Management LP 408,496$7,565,0000.55%
BVF INC/IL 134,725$2,495,0000.44%
Baker Brothers Advisors 2,335,125$43,247,0000.38%
SPHERA FUNDS MANAGEMENT LTD. 209,027$3,696,0000.36%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 461,530$8,548,0000.28%
MARINER INVESTMENT GROUP LLC 50,665$938,0000.24%
TIVERTON ASSET MANAGEMENT LLC 450,000$8,334,0000.17%
RIVERHEAD CAPITAL MANAGEMENT LLC 415,377$7,693,0000.12%
View complete list of ATYR PHARMA INC shareholders